Abstract: A battery pack includes a cell module including at least one cell, a first collecting module including at least one first collecting unit arranged in the cell and configured to collect first operation data of the cell, and a data processing module connected with the first collecting unit and configured to perform a thermal runaway detection on the cell based on the first operation data to obtain a first detection result.

Abstract: The present disclosure provides data-driven methods and apparatuses for predicting user inquiries. One exemplary method includes: collecting user behavior data and pre-processing the user behavior data when a user inquiry is received; extracting candidate user behavior data that is contributive to the user inquiry from the pre-processed user behavior data; screening the candidate user behavior data based on a set target behavior data set, and selecting candidate user behavior data that is contained in the target behavior data set; inputting the screened candidate user behavior data into a trained classifier model; and predicting an inquiry category to which the user inquiry belongs. One exemplary apparatus includes a pre-processing module, an extraction module, and a prediction module. The method and the apparatus embodiments of the present disclosure can improve the efficiency and accuracy of the prediction.

Abstract: The present disclosure provides a method and apparatus for generating speech through neural text-to-speech (TTS) synthesis. A text input may be obtained. A phone feature of the text input may be generated. Context features of the text input may be generated based on a set of sentences associated with the text input. A speech waveform corresponding to the text input may be generated based on the phone feature and the context features.

Abstract: Antibodies having binding specificity to CD44 v7/8, (a.k.a. CD44 variant 7/8) and antibody-drug conjugates (ADCs) or chimeric antigen receptors comprising such. Also provided herein are uses the anti-CD44 v7/8 antibodies, the ADCs, or immune cells expressing the chimeric antigen receptors for therapeutic and diagnostic purposes.

Abstract: Antibodies specific to MUC18 (a.k.a. MCAM or CD146) and antibody-drug conjugates (ADCs) comprising such. Also provided herein are uses the the anti-MUC18 antibodies or ADCs for therapeutic and diagnostic purposes.

Abstract: The present disclosure relates to systems and methods for determining a potential malicious event. The systems and methods may obtain real-time information related to a vehicle. The systems and methods may determine a probability of arising malicious event based on the real-time information of the vehicle. The systems and methods may determine whether the probability of arising malicious event exceeds a probability threshold. The systems and methods may in response to a determination that the probability of arising malicious event exceeds the probability threshold, determine that a potential malicious event exists.

Abstract: Described herein are bacteriochlorins comprising an annulated isocyclic ring such as a compound Formula I: or a metal conjugate thereof, wherein: R1, R2, R3, R4, R5, R6, R7, R8, R9, R10, R11, R12, R13, R14, R15, R16, and Z are each as defined herein. Also described are methods and intermediates for the synthesis of bacteriochlorins comprising an annulated isocyclic ring, and methods of using such bacteriochlorins for, among other things, diagnostic and therapeutic purposes such as, e.g., luminescent compounds in flow cytometry, and/or as active agents in photodynamic therapy (PDT).

Abstract: Described herein are bacteriochlorins comprising an annulated isocyclic ring. Also described are methods and intermediates for the synthesis of bacteriochlorins comprising an annulated isocyclic ring, and methods of using such bacteriochlorins for, among other things, diagnostic and therapeutic purposes such as, e.g., luminescent compounds in flow cytometry, and/or as active agents in photodynamic therapy (PDT).